MedPath

Combined Pericapsular Nerve Group Block and Lateral Femoral Cutaneous Nerve Block for Pediatric Hip Surgeries

Phase 2
Recruiting
Conditions
Pericapsular Nerve Group Block
Interventions
Procedure: Ultrasound-guided Combined Pericapsular Nerve Group Block
Procedure: Caudal epidural analgesia
Procedure: Ultrasound-guided Lateral Femoral Cutaneous Nerve Block
Registration Number
NCT06417268
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

combined pericapsular nerve group PENG block and lateral femoral cutaneous nerve block may be effective in reducing post-operative pain after open hip surgery in children.

Detailed Description

All children will be assessed clinically, and investigations will be done to exclude the exclusion criteria mentioned above. Laboratory works needed: complete blood count (CBC), prothrombin time, concentration, partial thromboplastin time. Midazolam (0.5mg/kg) will be given orally to each child in both groups as a premedication half an hour before the procedure.

General anesthesia will be induced in a supine position under standard basic monitoring of vital signs with inhalational anesthetic using (100%) O2 + Sevoflurane.

Group C will receive caudal analgesia Bupivacaine 0.25% at a dose of 1 ml/kg. Group B will receive PENG block Bupivacaine 0.25% at a dose of 1 ml/kg and lateral femoral cutaneous nerve block Bubivacaine 0.25% at 0.1 ml/kg.

After receiving the block, a surgical incision will be done after 15 minutes. Continuous recording of heart rate and blood pressure will be carried out from the moment of injection at timely intervals intra-operative. Intra-operatively, an increase in hemodynamics in response to the skin incision by more than 30% from baseline values 5 min after intubation or thereafter is managed by intravenous administration of fentanyl 1 µg/kg to a maximum dose of 2 µg/kg. Postoperative pain assessment using the FLACC score will then follow for 24 hours.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
68
Inclusion Criteria
  • American Society of Anesthesiologists (ASA) physical status I, II.
  • Unilateral hip surgery.
Exclusion Criteria
  • Parents' refusal to participate in the study.
  • Coagulopathy (i.e. Platelets ≤ 50,000 and/or INR> 1.5).
  • Localized infection at the site of needle insertion.
  • Known hypersensitivity or allergies to any of the used drugs.
  • Bilateral hip surgery in the same session.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group BUltrasound-guided Combined Pericapsular Nerve Group Blockpatients will receive PENG block and Lateral Femoral Cutaneous Nerve block
Group CCaudal epidural analgesiaPatients will receive caudal analgesia
Group BUltrasound-guided Lateral Femoral Cutaneous Nerve Blockpatients will receive PENG block and Lateral Femoral Cutaneous Nerve block
Group CFentanylPatients will receive caudal analgesia
Group CMorphinePatients will receive caudal analgesia
Group CAcetaminophenPatients will receive caudal analgesia
Group BFentanylpatients will receive PENG block and Lateral Femoral Cutaneous Nerve block
Group BMorphinepatients will receive PENG block and Lateral Femoral Cutaneous Nerve block
Group BAcetaminophenpatients will receive PENG block and Lateral Femoral Cutaneous Nerve block
Primary Outcome Measures
NameTimeMethod
Time to first rescue analgesiaFirst 24 hours postoperative

Time (minutes) to first need of rescue analgesia postoperative.

Secondary Outcome Measures
NameTimeMethod
Intraoperative hemodynamic parametersintraoperative period

heart rate (bpm)

Total fentanyl consumptionintraoperative period

total intraoperative consumed fentanyl (mg/kg)

Total morphine consumptionFirst 24 hours postoperative

total postoperative consumed morphine (mg/kg)

Postoperative pain assessment FLACCFirst 24 hours postoperative

In the PACU, quality of analgesia was assessed every 15 minutes for the first hour then after 2, 4 ,6 ,12,18 and 24 hours postoperative using (face, legs, activity, and cry consolability scale) (FLACC) pain score

Trial Locations

Locations (1)

Cairo University Hospitals

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath